Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus

Published:2021-01-01 Issue:1 Volume:14 Page:333-339
ISSN:2689-5293
Container-title:All Life
language:en
Short-container-title:All Life

Author:

Zhao Chunzhi¹,Li Xing²,Ma Jianhua³,Zhu Zhengtai¹,Li Hua¹,Lou Fangli⁴,Zhai Yuefang¹,Chen Hui¹,Xiao Shujun¹,Peng Qinhui¹,Hua Huilian⁵,Zhang Qing¹,Lou Fangyong⁶

Affiliation:

1. Department of Geriatrics, Taizhou Peoples Hospital, Taizhou, People’s Republic of China

2. Department of Endocrinology, The Second Affiliated Shanxi Medical University, Taiyuan, People’s Republic of China

3. Department of Endocrinology, The Affiliated Nanjing Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

4. Nursing School of Guizhou University of Traditional Chinese Medicine, Guiyang, People’s Republic of China

5. Department of Pharmacy, Taizhou Peoples Hospital, Taizhou, People’s Republic of China

6. Department of Orthopaedics, Taizhou Peoples Hospital, Taizhou, People’s Republic of China

Funder

T2DM

NAFLD

Publisher

Informa UK Limited

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/26895293.2021.1917457

Reference27 articles.

1. Gliclazide

2. Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients

3. The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents

4. Cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population‐based study (The Ayrshire Diabetes Follow‐up Cohort study)

5. Pathogenesis of type 2 diabetes mellitus